BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29058791)

  • 21. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
    Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
    Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
    Front Immunol; 2020; 11():576743. PubMed ID: 33519801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface.
    Wang S; Zhu X; Xu Y; Zhang D; Li Y; Tao Y; Piao H; Li D; Du M
    Hum Reprod; 2016 Apr; 31(4):700-11. PubMed ID: 26908841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma.
    Nowicki TS; Akiyama R; Huang RR; Shintaku IP; Wang X; Tumeh PC; Singh A; Chmielowski B; Denny C; Federman N; Ribas A
    Cancer Immunol Res; 2017 Feb; 5(2):118-126. PubMed ID: 28039162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation.
    Hartley GP; Chow L; Ammons DT; Wheat WH; Dow SW
    Cancer Immunol Res; 2018 Oct; 6(10):1260-1273. PubMed ID: 30012633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4
    Zhang A; Xiong Y; Xu F; Wang Z; Ma J; Zhao N; Hu T; Yi J; Zhou Y; Luan X
    Cell Immunol; 2020 Jun; 352():104113. PubMed ID: 32331794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
    de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
    Front Immunol; 2020; 11():574491. PubMed ID: 33193363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8
    Suarez GV; Melucci Ganzarain CDC; Vecchione MB; Trifone CA; Marín Franco JL; Genoula M; Moraña EJ; Balboa L; Quiroga MF
    Sci Rep; 2019 Jan; 9(1):187. PubMed ID: 30655556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides.
    Grywalska E; Smarz-Widelska I; Krasowska-Zajac E; Korona-Glowniak I; Zaluska-Patel K; Mielnik M; Podgajna M; Malm A; Rolinski J; Zaluska W
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):133-143. PubMed ID: 28770269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression.
    Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
    Anticancer Res; 2018 Jan; 38(1):107-112. PubMed ID: 29277762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
    Li W; Tu J; Liu X; Yang W
    Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract.
    Shen Z; Rodriguez-Garcia M; Patel MV; Barr FD; Wira CR
    Am J Reprod Immunol; 2016 Aug; 76(2):118-25. PubMed ID: 27321759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes.
    Li X; Zhong T; Tang R; Wu C; Xie Y; Liu F; Zhou Z
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32236416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.
    Braun NA; Celada LJ; Herazo-Maya JD; Abraham S; Shaginurova G; Sevin CM; Grutters J; Culver DA; Dworski R; Sheller J; Massion PP; Polosukhin VV; Johnson JE; Kaminski N; Wilkes DS; Oswald-Richter KA; Drake WP
    Am J Respir Crit Care Med; 2014 Sep; 190(5):560-71. PubMed ID: 25073001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-1 and PD-L1 expression on T-cell subsets in women with unexplained recurrent pregnancy losses.
    Wang WJ; Salazar Garcia MD; Deutsch G; Sung N; Yang X; He Q; Jubiz G; Bilal M; Dambaeva S; Gilman-Sachs A; Beaman K; Kwak-Kim J
    Am J Reprod Immunol; 2020 May; 83(5):e13230. PubMed ID: 32086851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis.
    Hu YM; Hsiung YC; Pai MH; Yeh SL
    JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):538-549. PubMed ID: 28633555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
    Ding Y; Han R; Jiang W; Xiao J; Liu H; Chen X; Li X; Hao J
    J Immunol; 2016 Nov; 197(10):3831-3840. PubMed ID: 27798164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.
    Takeda Y; Kataoka K; Yamagishi J; Ogawa S; Seya T; Matsumoto M
    Cell Rep; 2017 May; 19(9):1874-1887. PubMed ID: 28564605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior irradiation results in elevated programmed cell death protein 1 (PD-1) in T cells.
    Li D; Chen R; Wang YW; Fornace AJ; Li HH
    Int J Radiat Biol; 2018 May; 94(5):488-494. PubMed ID: 29108460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.